Avoro Capital Advisors LLC Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$7.7T
Holdings
30
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (30 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA | 5,110,000 | $1.0T | 13.13% | |
| 2 | UTHUNITED THERAPEUTICS CORP | 2,222,222 | $852.2B | 11.02% | Call |
| 3 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,833,000 | $840.7B | 10.87% | |
| 4 | ARGXARGENX SE | 990,000 | $730.2B | 9.44% | |
| 5 | KRYSKRYSTAL BIOTECH INC | 2,777,777 | $490.4B | 6.34% | |
| 6 | ARWRARROWHEAD PHARMACEUTICALS INC. | 10,900,000 | $375.9B | 4.86% | |
| 7 | KYMRKYMERA THERAPEUTICS INC | 6,350,000 | $359.4B | 4.65% | |
| 8 | MRUSMERUS N V | 3,542,500 | $333.5B | 4.31% | |
| 9 | RNAAVIDITY BIOSCIENCES INC | 7,645,000 | $333.1B | 4.31% | |
| 10 | APLSAPELLIS PHARMACEUTICALS INC. | 12,222,222 | $276.6B | 3.58% | |
| 11 | CNTACENTESSA PHARMACEUTICALS PLC | 10,808,080 | $262.1B | 3.39% | |
| 12 | QUREUNIQURE NV | 4,444,444 | $259.4B | 3.35% | |
| 13 | XENEXENON PHARMACEUTICALS INC | 5,400,000 | $216.8B | 2.80% | |
| 14 | AKROAKERO THERAPEUTICS INC | 3,955,555 | $187.8B | 2.43% | |
| 15 | VERAVERA THERAPEUTICS INC | 6,210,000 | $180.5B | 2.33% | |
| 16 | SLNOSOLENO THERAPEUTICS INC | 2,577,777 | $174.3B | 2.25% | |
| 17 | GPCRSTRUCTURE THERAPEUTICS INC. | 5,405,555 | $146.6B | 1.89% | Call |
| 18 | TRMLTOURMALINE BIO INC | 2,555,555 | $122.2B | 1.58% | |
| 19 | OCULOCULAR THERAPEUTIX INC | 10,250,000 | $119.8B | 1.55% | |
| 20 | AM6AMICUS THERAPEUTICS INC. | 15,025,000 | $118.4B | 1.53% | |
| 21 | ETNBGBP89BIO INC | 6,387,790 | $93.9B | 1.21% | |
| 22 | TSHATAYSHA GENE THERAPIES INC | 21,700,000 | $71.0B | 0.92% | |
| 23 | ALKSALKERMES PLC | 2,240,000 | $67.2B | 0.87% | |
| 24 | ORKAORUKA THERAPEUTICS INC | 1,333,340 | $25.6B | 0.33% | |
| 25 | SEPNSEPTERNA INC | 1,337,500 | $25.2B | 0.33% | |
| 26 | MNKDMANNKIND CORP | 4,468,877 | $24.0B | 0.31% | |
| 27 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 2,000,000 | $14.3B | 0.19% | |
| 28 | BCRXBIOCRYST PHARMACEUTICALS INC | 1,250,000 | $9.5B | 0.12% | |
| 29 | WHWKWHITEHAWK THERAPEUTICS INC | 2,849,402 | $5.4B | 0.07% | |
| 30 | TNGXTANGO THERAPEUTICS INC | 545,000 | $4.6B | 0.06% |